The Androgen Deficiency in Aging Males (ADAM) questionnaire has been shown to be effective for screening patients with potential testosterone deficiency. Patients who may benefit most from screening include those with associated conditions such as: age >60 years, depression, diabetes, chronic narcotic use, and low libido.
Click Here for a downloadable pdf version of the ADAM Questionnaire in English
Click Here for a downloadable pdf version of the ADAM Questionnaire in Spanish
Safety Information
|
In geriatric patients, treatment with testosterone may increase the risk of developing benign prostatic hyperplasia and may promote the growth of existing prostate cancer. In clinical studies of 122 patients treated with Androderm, skin irritation from the patch was the most common adverse event (pruritus at application site [37%], burn-like blister reaction under system [12%], and erythema at application site [7%]). During such studies a total of 9% of patients discontinued Androderm treatment due either to chronic skin irritation or allergic contact dermatitis associated with the patch. Applying a small amount of 0.1% triamcinolone acetonide cream to the skin prior to patch application has been shown to reduce the incidence and severity of skin irritation. Androderm should not be applied over bone prominences or over areas subject to prolonged pressure. Androderm must not be used in women. Patients should remove Androderm before undergoing an MRI due to risk of skin burns. Androderm is indicated for testosterone replacement therapy in men for conditions associated with a deficiency or absence of endogenous testosterone. Please see Full Prescribing Information. |
References
References |
 |
 |
[1] Androderm® Physician Prescribing Information
|
||
 |
|
 |
